https://www.sikich.com

Sikich Investment Banking advises ORFLO Technologies in acquisition by Gemini Bio

Sikich

Nov 18 2019

2 min read

CHICAGO — Nov. 18, 2019 — Gemini Bio (“Gemini”), a cell culture solutions company, recently acquired ORFLO Technologies (“ORFLO”), a developer of cell and protein analysis instruments. Sikich Investment Banking served as the exclusive sell-side adviser to ORFLO Technologies.

“ORFLO’s innovative technology fits naturally into Gemini’s robust portfolio of solutions for cell and gene therapy research,” said Susan Tomilo, managing director at Sikich Investment Banking. “With implications for transformative CAR-T therapies, ORFLO’s products are on the front lines of innovation in the life sciences industry.”

Gemini Bio, a portfolio company of BelHealth Investment Partners, manufactures and supplies cell culture media, sera and other reagents to the biotechnology and biopharma industries as well as the academic community. ORFLO’s solutions facilitate more efficient cell quality control and analysis by uniquely combining the Coulter Principle with fluorescence in consumable microfluidic cassettes that run on fully integrated, robust platforms.

“Our products will strengthen Gemini’s ability to deliver high-quality solutions to cell culture laboratories around the world,” said Ted Ayliffe, founder and CEO of ORFLO Technologies. “Gemini’s strong team and extensive reach will help our technology penetrate more of the marketplace and contribute to innovations and accelerated achievement of research goals. Sikich was pivotal in making this deal happen, and I would recommend Sikich to any life science company who is looking for a top-shelf investment banker to represent them.”

Sikich Investment Banking offers mergers and acquisitions and capital markets advisory services. The team has deep experience across many industries, particularly technology, manufacturing and distribution, health care and life sciences, and business and professional services.

Transaction terms were not disclosed.

This publication contains general information only and Sikich is not, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or any other professional advice or services. This publication is not a substitute for such professional advice or services, nor should you use it as a basis for any decision, action or omission that may affect you or your business. Before making any decision, taking any action or omitting an action that may affect you or your business, you should consult a qualified professional advisor. In addition, this publication may contain certain content generated by an artificial intelligence (AI) language model. You acknowledge that Sikich shall not be responsible for any loss sustained by you or any person who relies on this publication.

About the Author

Sikich

Sikich is a global company specializing in technology-enabled professional services. With more than 1,900 employees, Sikich draws on a diverse portfolio of technology solutions to deliver transformative digital strategies and is comprised of one of the largest CPA firms in the United States. From corporations and not-for-profits to state and local governments and federal agencies, Sikich clients utilize a broad spectrum of services* and products to help them improve performance and achieve long-term, strategic goals. *Securities offered through Sikich Corporate Finance LLC, member FINRA/SIPC. Investment advisory services offered through Sikich Financial, an SEC Registered Investment Advisor. 